Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S. Sundstrøm S, et al. Among authors: johannessen dc. J Clin Oncol. 2004 Mar 1;22(5):801-10. doi: 10.1200/JCO.2004.06.123. J Clin Oncol. 2004. PMID: 14990635 Clinical Trial.
Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences.
Muren LP, Wasbø E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, Valen H, Ekerold R, Johannessen DC. Muren LP, et al. Among authors: johannessen dc. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1034-41. doi: 10.1016/j.ijrobp.2007.11.060. Epub 2008 Feb 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18249502 Free article. Clinical Trial.
[Re: Different guidelines for treatment of prostate cancer].
Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A. Solberg A, et al. Tidsskr Nor Laegeforen. 2015 Jun 30;135(12-13):1105. doi: 10.4045/tidsskr.15.0652. eCollection 2015 Jun 30. Tidsskr Nor Laegeforen. 2015. PMID: 26130530 Free article. Norwegian. No abstract available.
Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer.
Ekanger C, Helle SI, Heinrich D, Johannessen DC, Karlsdóttir Á, Nygård Y, Halvorsen OJ, Reisæter L, Kvåle R, Hysing LB, Dahl O. Ekanger C, et al. Among authors: johannessen dc. Adv Radiat Oncol. 2019 Dec 9;5(3):396-403. doi: 10.1016/j.adro.2019.11.007. eCollection 2020 May-Jun. Adv Radiat Oncol. 2019. PMID: 32529133 Free PMC article.
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
Hoskin P, Sartor O, O'Sullivan JM, Johannessen DC, Helle SI, Logue J, Bottomley D, Nilsson S, Vogelzang NJ, Fang F, Wahba M, Aksnes AK, Parker C. Hoskin P, et al. Among authors: johannessen dc. Lancet Oncol. 2014 Nov;15(12):1397-406. doi: 10.1016/S1470-2045(14)70474-7. Epub 2014 Oct 17. Lancet Oncol. 2014. PMID: 25439694 Clinical Trial.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C. Sartor O, et al. Among authors: johannessen dc. Lancet Oncol. 2014 Jun;15(7):738-46. doi: 10.1016/S1470-2045(14)70183-4. Epub 2014 May 13. Lancet Oncol. 2014. PMID: 24836273 Clinical Trial.
32 results